Healthcare provider profile · identity verified

Pushkala Muralitharan

Internal Medicine · CONCORD, NH · NPI 1700806304

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	464	128
Levothyroxine Sodium	Levothyroxine Sodium	339	89
Amlodipine Besylate	Amlodipine Besylate	269	71
Omeprazole	Omeprazole	234	62
Simvastatin	Simvastatin	219	56
Rosuvastatin Calcium	Rosuvastatin Calcium	213	65
Pantoprazole Sodium	Pantoprazole Sodium	206	51
Lisinopril	Lisinopril	199	57
Metoprolol Succinate	Metoprolol Succinate	173	44
Metformin Hcl	Metformin Hcl	164	42
Furosemide	Furosemide	158	43
Losartan Potassium	Losartan Potassium	124	39
Gabapentin	Gabapentin	115	37
Albuterol Sulfate Hfa	Albuterol Sulfate	114	42
Atenolol	Atenolol	107	30
Duloxetine Hcl	Duloxetine Hcl	105	21
Sertraline Hcl	Sertraline Hcl	104	24
Trazodone Hcl	Trazodone Hcl	104	29
Synthroid	Levothyroxine Sodium	103	32
Hydrochlorothiazide	Hydrochlorothiazide	99	30
Escitalopram Oxalate	Escitalopram Oxalate	97	26
Alprazolam	Alprazolam	92	20
Eliquis	Apixaban	85	18
Oxycodone Hcl	Oxycodone Hcl	83	15
Lorazepam	Lorazepam	81	17
Metformin Hcl Er	Metformin Hcl	78	19
Clopidogrel	Clopidogrel Bisulfate	69	17
Metoprolol Tartrate	Metoprolol Tartrate	69	18
Venlafaxine Hcl Er	Venlafaxine Hcl	64	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	62	15
Esomeprazole Magnesium	Esomeprazole Magnesium	61	12
Potassium Chloride	Potassium Chloride	58	17
Famotidine	Famotidine	56	14
Ozempic	Semaglutide	56	14
Torsemide	Torsemide	55	14
Prednisone	Prednisone	54	22
Warfarin Sodium	Warfarin Sodium	54	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	52	suppressed
Chlorthalidone	Chlorthalidone	51	13
Fluticasone Propionate	Fluticasone Propionate	51	23
Allopurinol	Allopurinol	50	15
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	49	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	48	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	47	11
Clonazepam	Clonazepam	46	suppressed
Tramadol Hcl	Tramadol Hcl	45	13
Citalopram Hbr	Citalopram Hydrobromide	43	11
Glimepiride	Glimepiride	43	suppressed
Ezetimibe	Ezetimibe	42	11
Mirtazapine	Mirtazapine	41	suppressed
Bupropion Xl	Bupropion Hcl	37	suppressed
Mounjaro	Tirzepatide	37	suppressed
Pregabalin	Pregabalin	36	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	35	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	34	suppressed
Montelukast Sodium	Montelukast Sodium	34	12
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Estradiol	Estradiol	30	13
Glipizide Er	Glipizide	30	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	29	suppressed
Bupropion Hcl Sr	Bupropion Hcl	29	suppressed
Januvia	Sitagliptin Phosphate	29	11
Meloxicam	Meloxicam	29	suppressed
Glipizide	Glipizide	28	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	27	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	26	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	26	suppressed
Paroxetine Hcl	Paroxetine Hcl	26	suppressed
Rybelsus	Semaglutide	26	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	26	suppressed
Celecoxib	Celecoxib	25	suppressed
Azithromycin	Azithromycin	24	14
Donepezil Hcl	Donepezil Hcl	24	suppressed
Spironolactone-Hctz	Spironolact/Hydrochlorothiazid	24	suppressed
Morphine Sulfate Er	Morphine Sulfate	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	21	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	21	suppressed
Pravastatin Sodium	Pravastatin Sodium	20	suppressed
Trulicity	Dulaglutide	20	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	19	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	19	suppressed
Methenamine Hippurate	Methenamine Hippurate	19	suppressed
Memantine Hcl	Memantine Hcl	18	suppressed
Nystatin	Nystatin	18	suppressed
Terazosin Hcl	Terazosin Hcl	18	suppressed
Topiramate	Topiramate	18	suppressed
Ipratropium Bromide	Ipratropium Bromide	17	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	17	suppressed
Olanzapine	Olanzapine	17	suppressed
Carvedilol	Carvedilol	16	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Lansoprazole	Lansoprazole	15	suppressed
Lovastatin	Lovastatin	15	suppressed
Ondansetron Odt	Ondansetron	15	suppressed
Acyclovir	Acyclovir	14	suppressed
Amoxicillin	Amoxicillin	14	suppressed
Buprenorphine Hcl	Buprenorphine Hcl	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Methimazole	Methimazole	14	suppressed
Methylphenidate Hcl	Methylphenidate Hcl	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Raloxifene Hcl	Raloxifene Hcl	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	14	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Colchicine	Colchicine	13	suppressed
Repaglinide	Repaglinide	13	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	13	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	12	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	12	suppressed
Cholestyramine Light	Cholestyramine	12	suppressed
Dilantin	Phenytoin Sodium Extended	12	suppressed
Dilt-Xr	Diltiazem Hcl	12	suppressed
Irbesartan	Irbesartan	12	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	12	suppressed
Benazepril Hcl	Benazepril Hcl	11	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	11	suppressed
Methotrexate	Methotrexate Sodium	11	suppressed
Methylprednisolone	Methylprednisolone	11	suppressed
Metronidazole	Metronidazole	11	suppressed
Nebivolol Hcl	Nebivolol Hcl	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error